[144] Bank of New York Mellon Corporation SEC Filing

Rhea-AI Filing Summary

Bank of New York Mellon Corp. (BK) insider J. Kevin McCarthy has filed Form 144 to sell up to 20,000 common shares via UBS Financial Services on or about 22 Jul 2025. Based on the filing’s reference price, the planned sale equals roughly $1.97 million, or 0.003% of the 715.4 million shares outstanding.

The shares derive from vested employee stock awards granted between 2020-2025. The notice also reveals that McCarthy sold 30,000 shares for $2.37 million on 29 Apr 2025. Rule 144 requires the filer to affirm no knowledge of undisclosed material information and to adhere to volume and timing limits.

The document contains no earnings or operational data; it purely alerts investors to incremental insider selling activity that is small relative to float but may influence sentiment monitoring.

Positive

• Planned sale equals only 0.003% of outstanding shares, implying negligible dilution or ownership shift.

Negative

• Insider J. Kevin McCarthy intends to sell 20,000 shares worth $1.97 million under Rule 144.
• Filer previously sold 30,000 shares for $2.37 million on 29 Apr 2025, indicating continued divestment.

Insights

Securities Analyst

TL;DR Insider McCarthy's Form 144 discloses intent to sell 20k BK shares, adding to 30k shares sold in April; modest but negative sentiment.

The filing signals continued insider monetisation: 20,000 shares (~$1.97 m) now and 30,000 shares (~$2.37 m) already sold within the last quarter. Although the combined 50,000 shares represent a negligible 0.007% of outstanding stock, insider sales can weigh on short-term sentiment, especially when clustered. No performance metrics are provided, so valuation impact is limited to behavioural interpretation. I classify the disclosure as modestly negative and not materially impactful for fundamentals.

Corporate Governance Expert

TL;DR Filing indicates orderly Rule144 sale using UBS; no material undisclosed info claimed; governance compliance evident, limited market impact.

Form 144 is a routine mechanism allowing affiliates to resell shares while maintaining transparency. The filer certifies knowledge of no undisclosed adverse information, aligning with governance best practices. Use of a major broker and adherence to Rule 144 volume/date constraints suggest an orderly process. Because the stake is immaterial relative to float, I view overall market impact as minimal and the filing as procedurally neutral.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services, Inc. 1285 Avenue of the Americas New York NY 10019	20000	1972000	715434285	07/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/26/2021	Vested Employee Stock Award	The Bank of New York Mellon Corporation			8974	02/26/2021	Vested Employee Stock Awards
Common Stock	02/11/2021	Vested Employee Stock Award	The Bank of New York Mellon Corporation			3290	02/11/2021	Vested Employee Stock Awards
Common Stock	02/26/2021	Vested Employee Stock Award	The Bank of New York Mellon Corporation			1597	02/26/2021	Vested Employee Stock Awards
Common Stock	02/26/2021	Vested Employee Stock Award	The Bank of New York Mellon Corporation			1111	02/26/2021	Vested Employee Stock Awards
Common Stock	02/26/2025	Vested Employee Stock Award	The Bank of New York Mellon Corporation			5025	02/26/2025	Vested Employee Stock Awards
Common Stock	02/24/2023	Vested Employee Stock Award	The Bank of New York Mellon Corporation			2	02/24/2023	Vested Employee Stock Awards
Common Stock	02/23/2024	Vested Employee Stock Award	The Bank of New York Mellon Corporation			2	02/23/2024	Vested Employee Stock Awards
Common Stock	02/23/2024	Vested Employee Stock Award	The Bank of New York Mellon Corporation			1	02/23/2024	Vested Employee Stock Awards
Common Stock	02/20/2020	Vested Employee Stock Award	The Bank of New York Mellon Corporation			1	02/20/2020	Vested Employee Stock Awards

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
J. Kevin McCarthy 240 Greenwich Street New York NY 10286	Common Stock	04/29/2025	30000	2367300

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many BK shares are proposed for sale in this Form 144?

The filer intends to sell 20,000 common shares of Bank of New York Mellon.

What is the estimated market value of the shares to be sold?

The aggregate market value stated in the filing is $1,972,000.

When is the approximate sale date for the proposed transaction?

The filing lists an approximate sale date of 07/22/2025.

Which broker will execute the sale of BK shares?

The shares will be sold through UBS Financial Services, Inc.

Has the filer sold BK shares in the past three months?

Yes. The filing discloses a prior sale of 30,000 shares on 04/29/2025 for gross proceeds of $2.37 million.

How were the shares being sold originally acquired?

They were obtained via vested employee stock awards granted between 2020 and 2025.